The European Medicines Agency
(EMA) has revised its guidelines
relating to accelerated assessment
and conditional marketing
authorisation, two key elements
of the European legislation to
accelerate patients’ access to
medicines that address unmet
medical needs.
With the EMA still seeking
feedback on these guidelines,
submissions can be made up until
30 Sep - CLICK HERE for details.The above article was sent to subscribers in Pharmacy Daily's issue from 30 Jul 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Jul 15
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.